Prognostic significance of poorly cohesive gastric carcinoma in Tunisian patients.

Abdominal surgery Biological sciences Cancer surgery Gastric cancer Health sciences Pathology Poorly cohesive carcinoma Prognosis Survival

Journal

Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 04 09 2019
revised: 07 10 2019
accepted: 18 02 2020
entrez: 21 3 2020
pubmed: 21 3 2020
medline: 21 3 2020
Statut: epublish

Résumé

While the incidence of gastric cancer has decreased worldwide in recent decades, the incidence of poorly cohesive carcinoma (PCC) is rising. The prognostic significance of gastric PCC remains a subject of debate. To analyze the prognosis of gastric PCC in a Tunisian cohort. A total of 122 gastric adenocarcinoma patients who underwent curative gastrectomy from 2001 to 2014 at Habib Thameur hospital in Tunis, Tunisia were included. The clinicopathological parameters and prognosis of PCC were analyzed in comparison with non PCC (NPCC). Sixty one patients (50%) presented PCC. Patients were younger in PCC group (p = 0,001). There was no difference in sex distribution between the two groups. PCC was more likely to be stage T4 (55.7% vs 34.4%; p = 0.033), N3 (67.8% vs 30%; p < 0.001) and have a higher metastatic lymph node ratio (p < 0.001). Hepatic metastases were more frequent in NPCC group (p = 0.031) whereas peritoneal carcinomatosis was more common in PCC group (p = 0.004). Perineural invasion was more frequent in PCC group (p = 0.001). Resection margins were more often positive in PCC group (31.1% vs 9.8%; p = 0.004). There was no difference in recurrence rate between the 2 groups (p = 0.348). The 5-year survival was similar in the NPCC and PCC (respectively 43% vs 23 %; p = 0.247). Survival rates were also comparable in early stage (100% vs 80% respectively for PCC and NPCC; p = 0.527) as well as for advanced stage (16% vs 35% respectively for PCC and NPCC; p = 0.538). PCC was not a prognostic factor for survival. Interestingly, advanced age, adjacent structures invasion, positive resection margins were specific prognostic factors for PCC. In our study PCC was not a prognostic factor for survival. Advanced age, adjacent structures invasion and positive resection margins were specific prognostic features for this histological subtype.

Sections du résumé

BACKGROUND BACKGROUND
While the incidence of gastric cancer has decreased worldwide in recent decades, the incidence of poorly cohesive carcinoma (PCC) is rising. The prognostic significance of gastric PCC remains a subject of debate.
OBJECTIVE OBJECTIVE
To analyze the prognosis of gastric PCC in a Tunisian cohort.
METHODS METHODS
A total of 122 gastric adenocarcinoma patients who underwent curative gastrectomy from 2001 to 2014 at Habib Thameur hospital in Tunis, Tunisia were included. The clinicopathological parameters and prognosis of PCC were analyzed in comparison with non PCC (NPCC).
RESULTS RESULTS
Sixty one patients (50%) presented PCC. Patients were younger in PCC group (p = 0,001). There was no difference in sex distribution between the two groups. PCC was more likely to be stage T4 (55.7% vs 34.4%; p = 0.033), N3 (67.8% vs 30%; p < 0.001) and have a higher metastatic lymph node ratio (p < 0.001). Hepatic metastases were more frequent in NPCC group (p = 0.031) whereas peritoneal carcinomatosis was more common in PCC group (p = 0.004). Perineural invasion was more frequent in PCC group (p = 0.001). Resection margins were more often positive in PCC group (31.1% vs 9.8%; p = 0.004). There was no difference in recurrence rate between the 2 groups (p = 0.348). The 5-year survival was similar in the NPCC and PCC (respectively 43% vs 23 %; p = 0.247). Survival rates were also comparable in early stage (100% vs 80% respectively for PCC and NPCC; p = 0.527) as well as for advanced stage (16% vs 35% respectively for PCC and NPCC; p = 0.538). PCC was not a prognostic factor for survival. Interestingly, advanced age, adjacent structures invasion, positive resection margins were specific prognostic factors for PCC.
CONCLUSION CONCLUSIONS
In our study PCC was not a prognostic factor for survival. Advanced age, adjacent structures invasion and positive resection margins were specific prognostic features for this histological subtype.

Identifiants

pubmed: 32195384
doi: 10.1016/j.heliyon.2020.e03460
pii: S2405-8440(20)30305-4
pii: e03460
pmc: PMC7078324
doi:

Types de publication

Journal Article

Langues

eng

Pagination

e03460

Informations de copyright

© 2020 Published by Elsevier Ltd.

Références

Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Gastric Cancer. 2016 Oct;19(4):1027-1040
pubmed: 26606931
Surgery. 2013 Nov;154(5):1093-9
pubmed: 24075273
J Surg Oncol. 2013 Feb;107(2):124-9
pubmed: 22991272
Ann Surg Oncol. 2014 May;21(5):1739-48
pubmed: 24419755
J Gastrointest Oncol. 2016 Aug;7(4):523-9
pubmed: 27563441
J Surg Oncol. 2011 Jun 1;103(7):700-3
pubmed: 21308685
Medicine (Baltimore). 2014 Dec;93(27):e136
pubmed: 25501051
J Clin Oncol. 2012 Oct 1;30(28):3493-8
pubmed: 22927530
Gastric Cancer. 2014 Apr;17(2):341-7
pubmed: 23739764
Pathol Oncol Res. 2017 Oct;23(4):881-887
pubmed: 28116561
J Clin Oncol. 2012 Oct 1;30(28):3507-15
pubmed: 22949151
Ann Surg Oncol. 2010 Dec;17(12):3077-9
pubmed: 20882416
Transl Gastroenterol Hepatol. 2016 Aug 09;1:62
pubmed: 28138628
J Visc Surg. 2015 Dec;152(6):357-61
pubmed: 26481069
Int J Clin Exp Pathol. 2014 Aug 15;7(9):5692-700
pubmed: 25337210
Ann Surg. 2017 May;265(5):946-953
pubmed: 27232252
PLoS One. 2015 Dec 07;10(12):e0144420
pubmed: 26642199
J Surg Oncol. 2016 Oct;114(5):607-612
pubmed: 27562147
Acta Pathol Microbiol Scand. 1965;64:31-49
pubmed: 14320675
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S832-9
pubmed: 26156656
J Hematol Oncol. 2015 May 15;8:52
pubmed: 25976888
Ann Surg Oncol. 2015 Oct;22(11):3632-9
pubmed: 25676845
Lancet Oncol. 2014 Jan;15(1):23-34
pubmed: 24314615
Dig Dis Sci. 2011 Jun;56(6):1749-56
pubmed: 21104129
J Exp Clin Cancer Res. 2014 Dec 21;33:110
pubmed: 25528067

Auteurs

Raja Jouini (R)

Department of Pathology, Habib Thameur Hospital, Tunis, Tunisia.
Faculty of Medicine of Tunis, Tunis El Manar University, Tunisia.

Fatma Khanchel (F)

Department of Pathology, Habib Thameur Hospital, Tunis, Tunisia.
Faculty of Medicine of Tunis, Tunis El Manar University, Tunisia.

Meriam Sabbah (M)

Department of Gastroenterology, Habib Thameur Hospital, Tunis, Tunisia.
Faculty of Medicine of Tunis, Tunis El Manar University, Tunisia.

Imen Helal (I)

Department of Pathology, Habib Thameur Hospital, Tunis, Tunisia.
Faculty of Medicine of Tunis, Tunis El Manar University, Tunisia.

Abdessalem Gharsallah (A)

Faculty of Medicine of Tunis, Tunis El Manar University, Tunisia.

Marwa Ferchichi (M)

Department of Pathology, Habib Thameur Hospital, Tunis, Tunisia.
Faculty of Sciences of Tunis, Tunis El Manar University, Tunisia.

Dhafer Hadded (D)

Faculty of Medicine of Tunis, Tunis El Manar University, Tunisia.
Department of Surgery, Habib Thameur Hospital, Tunisia.

Haithem Zaafouri (H)

Faculty of Medicine of Tunis, Tunis El Manar University, Tunisia.
Department of Surgery, Habib Thameur Hospital, Tunisia.

Ehsen Ben Brahim (E)

Department of Pathology, Habib Thameur Hospital, Tunis, Tunisia.
Faculty of Medicine of Tunis, Tunis El Manar University, Tunisia.

Anis Ben Maamer (A)

Faculty of Medicine of Tunis, Tunis El Manar University, Tunisia.
Department of Surgery, Habib Thameur Hospital, Tunisia.

Aschraf Chadli Debbiche (AC)

Department of Pathology, Habib Thameur Hospital, Tunis, Tunisia.
Faculty of Medicine of Tunis, Tunis El Manar University, Tunisia.

Classifications MeSH